Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 21, 2024; 30(11): 1533-1544
Published online Mar 21, 2024. doi: 10.3748/wjg.v30.i11.1533
Published online Mar 21, 2024. doi: 10.3748/wjg.v30.i11.1533
Table 6 Univariate analysis of the survival group and death group [n (%)]
| Item | Survival group (n = 56) | Death group (n = 44) | χ2 value | P value |
| Age | ||||
| ≤ 60 yr | 43 (76.79) | 29 (65.91) | 1.446 | 0.229 |
| > 60 yr | 13 (23.21) | 15 (34.09) | ||
| Child-Pugh grade | ||||
| Grade A | 45 (80.36) | 23 (52.27) | 8.931 | 0.003 |
| Grade B | 11 (19.64) | 21 (47.73) | ||
| History of hepatitis | ||||
| Yes | 18 (32.14) | 29 (65.91) | 11.278 | 0.001 |
| None | 38 (67.86) | 15(34.09) | ||
| Number of tumors | ||||
| 1 | 35 (62.50) | 15 (34.09) | 8.266 | 0.016 |
| 2 | 16 (28.57) | 20 (45.45) | ||
| 3 | 5 (8.93) | 9 (20.45) | ||
| Tumor size (cm) | ||||
| < 6 | 49 (87.50) | 15 (34.09) | 30.506 | <0.001 |
| 6-10 | 7 (12.50) | 29 (65.91) | ||
| Use of sorafenib | ||||
| Yes | 36 (64.29) | 14 (31.82) | 10.390 | 0.001 |
| No | 20 (35.71) | 30 (68.18) | ||
| Stage of liver cancer | ||||
| IIIB | 47 (83.93) | 20 (45.45) | 16.496 | < 0.001 |
| IIIC | 9 (16.07) | 24 (54.55) | ||
| Histological differentiation | ||||
| High | 28 (50.00) | 14 (31.82) | 6.810 | 0.033 |
| Low-moderate | 18 (32.14) | 12 (27.27) | ||
| Necrosis | 10 (17.86) | 18 (40.91) | ||
| Previous splenectomy | ||||
| Yes | 18 (32.14) | 30 (68.18) | 12.822 | < 0.001 |
| None | 38 (67.86) | 14 (31.82) |
- Citation: Yang LM, Wang HJ, Li SL, Gan GH, Deng WW, Chang YS, Zhang LF. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors. World J Gastroenterol 2024; 30(11): 1533-1544
- URL: https://www.wjgnet.com/1007-9327/full/v30/i11/1533.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i11.1533